Cariprazine 3 mg Oral Capsule
RxNorm 1667668
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1667668 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cariprazine 3 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Cariprazine 3 mg Oral Capsule
(Atom ID: 7272468)
PTPrescribable
Designated preferred name (PT):
Cariprazine (as cariprazine hydrochloride) 3 mg oral capsule
(Atom ID: 12725439)
PSNPrescribable
Prescribable Name (PSN):
Cariprazine 3 mg Oral Capsule
(Atom ID: 7272473)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely cariprazine (as cariprazine hydrochloride) 3 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 12727096)
Patient Education
Cariprazine
Cariprazine is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Cariprazine is also used to treat episodes of depression in people with bipolar I disorder (manic depressive disorder; a disease that causes episodes of mania, episodes of depression and other abnormal moods). It is also used as a short term treatment for episodes of mania or mixed episodes (symptoms of mania and depression that happen together) in people with bipolar I disorder. Cariprazine is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.